Key result
Many ICD tachytherapy deactivations still occur on the final day of life, necessitating earlier proactive counseling.
Why the study?
Despite improvements in anticipatory ICD tachytherapy deactivation practices, a plateau has been reached, with many deactivations still occurring on the final day of life.
Observational (n=1,606)
Despite initial improvements, anticipatory ICD tachytherapy deactivation rates have plateaued, with a third still occurring on the final day of life, highlighting a significant gap in end-of-life care planning.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Clinicians should integrate proactive ICD deactivation talks earlier in HF care; confirms persistent end-of-life shortfalls despite improvements.
AIMS: Implantable cardioverter-defibrillators (ICDs) may deliver painful shocks in the final phase of life. The European Heart Rhythm Association (EHRA) and Heart Rhythm Society (HRS) recommend advanced care planning and timely tachytherapy deactivation to prevent this. This study aims to evaluate anticipatory tachytherapy deactivation practices over an 18-year period and identify implementation gaps to explore strategies for improvement. METHODS AND RESULTS: Records of 1606 ICD or cardiac resynchronization therapy-defibrillator (CRT-D) patients (79% male; mean age 67 ± 10 years at implantation, 73 ± 10 at death) who died between 2006 and 2022 were reviewed. Heart failure (32%) and malignancy (15%) were the most common causes of death. Anticipatory tachytherapy deactivation occurred in 42% of patients. Deactivation rates increased 5.2% annually from 2006 to 2014 (P < 0.001), but plateaued from 2015 to 2022 (P = 0.403). Among deactivations, 33% occurred on the final day of life, mainly during hospitalization. CONCLUSION: Despite improvements in anticipatory tachytherapy deactivation practices, a plateau has been reached. Many deactivations still occur on the final day of life, underscoring the need for earlier and more proactive counselling. Integrating deactivation discussions into routine care, particularly for heart failure patients, will be essential to ensure patient-centered advanced care planning.
Jaff et al. (2026) conducted an observational in ICD or CRT-D patients in the final phase of life (n=1,606). Anticipatory tachytherapy deactivation was evaluated on Anticipatory tachytherapy deactivation rate (5.2% annual increase (2006-2014), p=<0.001). Anticipatory tachytherapy deactivation occurred in 42% of deceased ICD/CRT-D patients, with rates increasing 5.2% annually from 2006 to 2014 but plateauing from 2015 to 2022.
Synapse has enriched 10 related papers. Consider them for comparative context: